If you need more lookups,
subscriptions start at $34 USD/month.
Steve Chin Location
Shanghai, CN
Steve Chin Work
2023 -now Chief Medical Officer @
2020 -2023 Chief Medical Officer @
2018 -2020 Senior Medical Director, Immuno-Oncology, Global Clinical Development @
2017 -2018 Global and US GI Oncology Lead @ Eli Lilly and Company
2014 -2017 US Medical Lead, GI and H and N Oncology @ Eli Lilly and Company
2008 -2014 Assistant Professor @
2008 -2014 GI Medical Oncology @ Holling Cancer Center
2005 -2008 Assistant Professor @
Steve Chin Education
Boston University
Penn State College of Medicine
Wayne State University School of Medicine
Steve Chin Skills
Healthcare
Oncology
Clinical Research
Medicine
Life Sciences
Biotechnology
Medical Education
Internal Medicine
Cancer Research
Oncology Clinical Research
Clinical Trials
Drug Development
Pharmaceutical Industry
Biologics
Monoclonal Antibodies
Cancer Immunotherapy
Medical Writing
Targeted Therapies
Strategic Planning
Product Development
Clinical Development
Cancer
Research
Product Launch
Regulatory Submissions
Cross Functional Team Leadership
Sales
Cross Cultural Communication Skills
Drug Discovery
Steve Chin Summary
Steve Chin, based in Shanghai, CN, is currently a Chief Medical Officer at MediLink Therapeutics. Steve Chin brings experience from previous roles at Elpiscience Biopharmaceuticals, Inc., AstraZeneca and Eli Lilly and Company. Steve Chin holds a Boston University. With a robust skill set that includes Healthcare, Oncology, Clinical Research, Medicine, Life Sciences and more. Steve Chin has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Steve Chin?
Find contact details for 700 million professionals.